Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ALPL | P05186 | 1/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.54 |
| ▸ | ALPG | P10696 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1550910 | 0.90 | MAPT (0.46) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL28570620 | 0.81 | MAPT (0.46) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL8205651 | 0.81 | MAPT (0.46) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL3494874 | 0.77 | MAPT (0.44) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL10941393 | 0.77 | MEN1 (0.51) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL29631752 | 0.75 | MAPT (0.50) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL306543 | 0.75 | MAPT (0.50) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL28560105 | 0.74 | MAPT (0.44) | MAPTMEN1KMT2AALDH1A1MITF | |
| Hydrochloric Acid SCHEMBL10485854 | 0.73 | MAPT (0.49) | MAPTMEN1KMT2ARAB9APOLB | |
| SCHEMBL3276944 | 0.73 | MEN1 (0.56) | MAPTMEN1KMT2ARAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009003625-A1 | AMINOPHENOXAZINONE AS AN ANTI-TUMOUR AND ANTI-INFLAMMATORY AGENT | EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKILINIKUM (DE) | 2009-01-08 | — | — | WO | claimed |
| US-5693442-A | ELEMENT HAVING OVERCOAT OVERLYING CHARGE GENERATING LAYER COMPRISING DYE AND/OR ORGANIC PIGMENT AND COMPLEX OF INORGANIC OXIDE POLYMER AND CHARGE CARRIER | EASTMAN KODAK COMPANY (US) | 1997-12-02 | — | — | US | claimed |
| CN-119118944-A | Near infrared fluorescent small molecular probe and preparation method and application thereof | 南京科技职业学院 | 2024-12-13 | — | — | CN | disclosed |
| CN-113441135-B | Preparation method of 2-amino-3H-phenoxazin-3-one or derivative thereof | 兰州大学 | 2022-09-20 | — | — | CN | disclosed |
| CN-113441135-A | Preparation method of 2-amino-3H-phenoxazin-3-one or derivative thereof | 兰州大学 | 2021-09-28 | — | — | CN | disclosed |
| US-20160200769-A1 | Compound, Transitmycin, Effective Against Bacterial and Viral Pathogens | INDIAN COUNCIL OF MEDICAL RESEARCH (IN) | 2016-07-14 | — | — | US | disclosed |
| WO-2015022698-A1 | A COMPOUND, TRANSITMYCIN, EFFECTIVE AGAINST BACTERIAL AND VIRAL PATHOGENS | INDIAN COUNCIL OF MEDICAL RESEARCH (IN) | 2015-02-19 | — | — | WO | disclosed |
| US-7932050-B2 | Enzymatic substrates derived from phenoxazinone and their use as developers in detection of microorganisms with peptidase activity | BIOMERIEUX (FR) | 2011-04-26 | — | — | US | disclosed |
| US-20100324285-A1 | ANTIINFLAMMATORY AGENT COMPRISING 2-AMINOPHENOL OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20100028926-A1 | Novel enzymatic substrates derived from phenoxazinone and their use as developer in detection of microorganisms with peptidase activity | BIOMERIEUX (FR) | 2010-02-04 | — | — | US | disclosed |
| WO-2010003970-A2 | PHENOXAZINE DYES | Wetlands Incubator sprl (BE) | 2010-01-14 | — | — | WO | disclosed |
| US-5858571-A | TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0872903-A1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | Shin-Etsu Chemical Co., Ltd. (JP) | 1998-10-21 | — | — | EP | disclosed |
| US-5693442-A | ELEMENT HAVING OVERCOAT OVERLYING CHARGE GENERATING LAYER COMPRISING DYE AND/OR ORGANIC PIGMENT AND COMPLEX OF INORGANIC OXIDE POLYMER AND CHARGE CARRIER | EASTMAN KODAK COMPANY (US) | 1997-12-02 | — | — | US | disclosed |
| US-4861775-A | Pharmacological use of phenoxazinones | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-08-29 | — | — | US | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0260486-A1 | Pharmacologically active phenoxazinones, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-03-23 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324285-A1 | ANTIINFLAMMATORY AGENT COMPRISING 2-AMINOPHENOL OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT | PTGES2, PTGS2, PTGES | MAPT 2218/4885MEN1 4848/4885KMT2A 1434/4885 |
| US-20160200769-A1 | Compound, Transitmycin, Effective Against Bacterial and Viral Pathogens | MAVS, TIMM50, TREH | MAPT 583/4885MEN1 1882/4885KMT2A 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.